Antibiotic resistance: A "dark side" of biofilm-associated chronic infections

Polskie Archiwum Medycyny Wewnetrznej

Volumn 123, Issue 6, 2013, Pages 309-313

  Marcinkiewicz, Janusz ^a,b   Strus, Magdalena ^b,c   Pasich, Ewa ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

^b UNIVERSITY OF AGRICULTURE IN KRAKOW   (Poland)

^c JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Antibiotic resistance; Bacterial biofilms; Chronic infections; Dental plaque; Periodontitis

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL BIOFILM; BACTERIAL GROWTH; BIOFILM; DENTAL CARIES; DRUG DIFFUSION; FUNGAL BIOFILM; GRAM POSITIVE BACTERIUM; HOST RESISTANCE; HUMAN; INFECTION; MOUTH FLORA; NONHUMAN; PERIODONTAL DISEASE; POLYMICROBIAL BIOFILM; REVIEW; SYSTEMIC DISEASE; TOOTH PLAQUE; ANTIBIOTIC PROPHYLAXIS; BACTERIAL INFECTIONS; BACTERIUM; CHRONIC DISEASE; DRUG EFFECTS; INFLAMMATION; METABOLISM; MICROBIOLOGY; PERIODONTITIS;

ANTIBIOTIC PROPHYLAXIS; BACTERIA; BACTERIAL INFECTIONS; BIOFILMS; CHRONIC DISEASE; DRUG RESISTANCE, MICROBIAL; HUMANS; INFLAMMATION; PERIODONTITIS;

EID: 84882967387     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: 10.20452/pamw.1780     Document Type: Review

References (36)

1. Costeron JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science. 1999; 284: 1318-1322.
2. Høiby N, Ciofu O, Johansen HK, et al. The clinical impact of bacterial biofilms. Int J Oral Sci. 2011; 3: 55-65.
3. Clutterbuck AL, Woods EJ, Knottenbelt DC, et al. Biofilms and their relevance to veterinary medicine. Vet Microbiol. 2007; 121: 1-17.
4. Westgate SJ, Pervical SL, Knottenbelt DC, et al. Microbiology of equine wounds and evidence of bacterial biofilms. Vet Microbiol. 2011; 150: 152-159.
5. Kaplan JB. Antibiotic-induced biofilm formation. Int J Artif Organs. 2011; 34: 737-751.
6. Ghafoor A, Hay ID, Rehm BH. Role of exopolysaccharides in Pseudomonas aeruginosa biofilm formation and architecture. Appl Environ Microbiol. 2011; 77: 5238-5246.
7. Meyle E, Stroh P, Günther F, et al. Destruction of bacterial biofilms by polymorphonuclear neutrophils: relative contribution of phagocytosis, DNA release, and degranulation. Int J Artif Organs. 2010; 33: 608-620.
8. Stoodley P, Sauer K, Davies DG, Costerton JW. Biofilms as complex differentiated communities. Annu Rev Microbiol. 2002; 56: 187-209.
9. McDougald D, Rice SA, Barraud N, et al. Should we stay or should we go: mechanisms and ecological consequences for biofilm dispersal. Nat Rev Microbiol. 2011; 10: 39-50.
10. Percival SL, Emanuel C, Cutting KF, Williams DW. Microbiology of the skin and the role of biofilms in infection. Int Wound J. 2012; 9: 14-32.
11. Vlassova N, Han A, Zenilman JM, et al. New horizons for cutaneous microbiology: the role of biofilms in dermatological disease. Br J Dermatol. 2001; 165: 751-759.
12. Hojo K, Nagaoka S, Ohshima T, Maeda N. Bacterial interactions in dental biofilm development. J. Dent. Res. 2009; 88: 982-990.
13. Costerton JW. Anaerobic biofilm infections in cystic fibrosis. Mol Cell. 2002; 10: 699-700.
14. He XS, Shi WY. Oral microbiology: past, present and future. Int J Oral Sci. 2009; 1: 46-58.
15. Marsh PD, Moter A, Devine DA. Dental plaque biofilms: communities, conflict and control. Periodontol 2000. 2011; 55: 16-35.
16. Cugini C, Klepac-Ceral V, Rackaityte E, et al. Porphyromonas gingivalis: keeping the pathos out of the biont. J Oral Microbiol. 2013; 5.
17. Seymour GJ, Ford PJ, Cullinan MP, et al. Relationship between periodontal infections and systemic disease. Clin Microbiol Infect. 2007; 4: 3-10.
18. Ford PJ, Yamazaki K, Seymour GJ. Cardiovascular and oral disease interactions: what is the evidence? Prim Dent Care. 2007; 14: 59-66.
19. Mercanoglu F, Oflaz H, Oz O, et al. Endothelial dysfunction in patients with chronic periodontitis and its improvement after initial periodontal therapy. J Periodontol. 2004; 75: 1694-1700.
20. Mercado FB, Marshall RI, Klestov AC, Bartold PM. Relationship between rheumatoid arthritis and periodontitis. J Periodontol. 2001; 72: 779-787.
21. Drenkard E. Antimicrobial resistance of Pseudomonas aeruginosa biofilms. Microbes Infect. 2003; 5: 1213-1219.
22. Park QM, Young RL, Poch KR, et al. Neutrophil enhancement of Pseudomonas aeruginosa biofilm development: human F-Actin and DNA as targets for therapy. J Med Microbiol. 2009; 58: 492-502.
23. Høiby N, Bjarnsholt T, Givskov M, et al. Antibiotic resistance of bacterial biofilms. Int J Antimicrob Agents. 2010; 35: 322-332.
24. Mah TF, O'Toole GA. Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol. 2001; 9: 34-39.
25. Steward PS. Mechanisms of antibiotic resistance in bacterial biofilms. Int J Med. Microbiol. 2002; 292: 107-113.
26. Leid JG, Willson CJ, Shirtliff ME, et al. The exopolysaccharide alginate protects Pseudomonas aeruginosa biofilm bacteria from IFN-g-mediated macrophage killing. J Immunol. 2005; 175: 7512-7518.
27. Jesaitis AJ, Franklin MJ, Berglund D, et al. Compromised host defense on Pseudomonas aeruginosa biofilms: Characterization of neutrophil and biofilm interactions. J Immunol. 2003; 171: 4329-4339.
28. Martins M, Henriques M, Lopez-Ribot JL, Oliveira R. Addition of DNase improves the in vitro activity of antifungal drugs against Candida albicans biofilms. Mycoses. 2012; 55: 80-85.
29. Ammons MC, Copié V. Mini-review: Lactoferrin: a bioinspired, anti-biofilm therapeutic. Biofouling. 2013; 29: 443-455.
30. Guggenheim B, Meier A. In vitro effect of chlorhexidine mouth rinses on polyspecies biofilms. Schweiz Monatsschr Zahnmed. 2011; 121: 432-441.
31. Arweiler NB, Auschill TM, Sculean A. Antibacterial effect of taurolidine (2%) on established dental plaque biofilm. Clin Oral Invest. 2012; 16: 499-504.
32. Zeng X, Liu X, Bian L, et al. Synergistic effect of 14-Alpha-lipoyl andrographolide and various antibiotics on the formation of biofilms and production of exopolysaccharide and pyocyanin by Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2011; 55: 3015-3017.
33. Marcinkiewicz J. Taurine bromamine: a new therapeutic option in inflammatory skin diseases. Pol Arch Med Wewn. 2009; 119: 673-676.
34. Marcinkiewicz J, Strus M, Walczewska M, et al. Influence of taurine haloamines (TauCl and TauBr) on the development of Pseudomonas aeruginosa biofilm: a preliminary study. Adv Exp Med Biol. 2013; 775: 269-283.
35. Marcinkiewicz J, Wojas-Pelc A, Walczewska M, et al. Topical taurine bromamine, a new candidate in the treatment of moderate inflammatory acne vulgaris. Eur J Dermatol. 2008; 18: 433-439.
36. Boyen F, Eeckhaut V, Van Immerseel F, et al. Quorum sensing in veterinary pathogens: mechanisms, clinical importance and future perspectives. Vet Microbiol. 2009; 135: 187-195.